| Courtney Derus, | |
|
114 Grand Ave, Wausau, WI 54403-6214 | |
| (715) 845-7175 | |
| (715) 845-7142 |
| Full Name | Courtney Derus |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 114 Grand Ave, Wausau, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255765335 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 3605-57 (Wisconsin) | Primary |
| Entity Name | Elmergreen Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922173418 PECOS PAC ID: 5496909483 Enrollment ID: O20130128000409 |
News Archive
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
The Palm Beach Post, on the growth of concierge medicine: "As health reform prepares to send another 32 million people into the already stressed health system, some say that concierge medicine is the future — where the wealthy see the best primary care doctors in a luxury setting, and everyone else makes do with clinics staffed by 'physician extenders' such as nurse practitioners.
Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I trial, a prospective, 75-patient study of mild for the treatment of lumbar spinal stenosis. As presented at the Florida Society of Interventional Pain Physicians Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.
Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Derus, 114 Grand Ave, Wausau, WI 54403-6214 Ph: (715) 845-7175 | Courtney Derus, 114 Grand Ave, Wausau, WI 54403-6214 Ph: (715) 845-7175 |
News Archive
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
The Palm Beach Post, on the growth of concierge medicine: "As health reform prepares to send another 32 million people into the already stressed health system, some say that concierge medicine is the future — where the wealthy see the best primary care doctors in a luxury setting, and everyone else makes do with clinics staffed by 'physician extenders' such as nurse practitioners.
Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I trial, a prospective, 75-patient study of mild for the treatment of lumbar spinal stenosis. As presented at the Florida Society of Interventional Pain Physicians Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.
Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
Dr. Steven A. Benson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 3rd St Ste 319-b, Wausau, WI 54403 Phone: 715-848-0002 Fax: 715-848-0390 | |
Paul Hesse, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Stewart Ave Ste 270, Wausau, WI 54401 Phone: 715-842-8600 | |
Dr. Judith L. Voelz, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Stewart Ave, Suite 272-4, Wausau, WI 54401 Phone: 715-842-4091 | |
Natasha Suzanne Mallak, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 630 S 36th Ave, Wausau, WI 54401 Phone: 715-842-9500 | |
Anthony P Gillette, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 520 N 28th Ave, Ste 200, Wausau, WI 54401 Phone: 715-848-1346 Fax: 715-848-0640 | |
Dr. Katie Anne Dorsey, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 630 S 36th Ave, Wausau, WI 54401 Phone: 855-607-8242 | |
Dr. Eric M Anderson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 516 Mcclellan Street, Wausau, WI 54403 Phone: 715-834-2046 Fax: 715-834-7563 |